Dividend compounder review

HIMS

Hims Hers Health Inc · NYSE · US

Healthcare · Drug Manufacturers - Specialty & Generic

Chart Factor Intelligence Back to Screener
Score40.50/100
Confidence78.00/100
DecisionInsufficient Data
RatingAvoid
Scoring

Quality breakdown

Dividend Reliability 0.0 / 25 Payment history, cuts, growth, and regularity.
Dividend Sustainability 14.0 / 20 Payout, free cash flow, dividend cover, and debt.
Business Quality 16.5 / 25 Scale, cash generation, growth, margins, and returns.
Valuation Discipline 3.0 / 15 Yield, P/E, and price stretch versus long-term trend.
Long-Term Trend 7.0 / 15 Trend line, long return history, and drawdown control.
Metrics

Dividend and business context

Dividend Years0
Dividend Yield0.00%
Payout Ratio0.0%
Dividend Cut 5YNo
Net Income$128.4M
Free Cash Flow$57.4M
FCF Covers DividendUnknown
Debt / Equity2.54
P/E-
Revenue Growth 5Y73.6%
Net Margin-0.6%
ROE-2.7%
Price vs Trend-0.3%
3Y Return218.5%
5Y Return151.8%
CurrencyUSD
Warnings

Review flags

No usable dividend history found.
Debt to equity is elevated at 2.54.
Dividend diary

Activity record

HIMS dividend review warning Warning · Warning

Debt to equity is elevated at 2.54.